Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Emerging Infectious Agents and Blood Safety in Latin America

Full text
Author(s):
Levi, Jose Eduardo
Total Authors: 1
Document type: Journal article
Source: FRONTIERS IN MEDICINE; v. 5, MAR 14 2018.
Web of Science Citations: 0
Abstract

Historically, emerging infectious agents have been an important driving force toward the enhancement of blood safety, illustrated by the sharp reduction in the transmission of infectious agents by blood transfusion after human immunodeficiency virus (HIV) epidemics. In general, Latin American (LATAM) countries have introduced screening for microorganisms with proven blood transmission with some delay in comparison to developed countries, but, nowadays, all LATAM countries comply with a minimum standard of screening which includes Hepatitis B, C, HIV, Treponema pallidum, and Trypanosoma cruzi. Noticeably, all those agents, in addition to HTLV, cause chronic infections. By contrast, in the last decade, the region has witnessed explosive outbreaks of arboviral diseases, representing a new challenge to the blood system, threatening not only blood safety but also availability. So far, the clinical impact of transfusion-transmitted Dengue, Chikungunya, or Zika has not been evident, precluding immediate reaction from the authorities. A number of other arboviruses are endemic in the region and may, unpredictably, originate new epidemics. Several measures must be taken in preparedness for the potential emergence of another arbodisease. (AU)

FAPESP's process: 14/50093-8 - Prevention of transfusional transmitted malaria in São Paulo State
Grantee:José Eduardo Levi
Support Opportunities: Research Grants - Research in Public Policies for the National Health Care System (PP-SUS)